Effect of liraglutide on expression of inflammatory genes in type 2 diabetes
Abstract Anti-inflammatory effects of glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment in T2D may contribute to the cardiovascular benefits observed with GLP-1 RAs in outcome studies. We investigated if the GLP-1 RA liraglutide exerts anti-inflammatory effects through modulation of infl...
Guardado en:
Autores principales: | Emilie H. Zobel, Rasmus S. Ripa, Bernt J. von Scholten, Viktor Rotbain Curovic, Andreas Kjaer, Tine W. Hansen, Peter Rossing, Joachim Størling |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/44a015485b9644c7a5d5d44744afea42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial
por: Jacob K. Jensen, et al.
Publicado: (2021) -
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial
por: Andreas Kjær, et al.
Publicado: (2021) -
The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
por: Suvanjaa Sivalingam, et al.
Publicado: (2021) -
Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
por: Rigato M, et al.
Publicado: (2014) -
The Effect of Liraglutide on Epicardial Adipose Tissue in Type 2 Diabetes
por: Na Zhao, et al.
Publicado: (2021)